4//SEC Filing
ACC International Holdings Ltd. 4
Accession 0001104659-20-084119
CIK 0001137883other
Filed
Jul 15, 8:00 PM ET
Accepted
Jul 16, 5:05 PM ET
Size
13.1 KB
Accession
0001104659-20-084119
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2020-07-16$13.47/sh−7,823$105,351→ 67,053 total - Sale
Common Stock
2020-07-09$13.13/sh−3,500$45,939→ 135,306 total - Sale
Common Stock
2020-07-10$13.35/sh−2,000$26,700→ 133,306 total - Sale
Common Stock
2020-07-13$13.52/sh−40,000$540,952→ 93,306 total - Sale
Common Stock
2020-07-15$13.12/sh−18,430$241,715→ 74,876 total
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.0816 to $13.1581, inclusive. The Reporting Person undertakes to provide to the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.338 to $13.61, inclusive. The Reporting Person undertakes to provide to the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.1 to $13.15, inclusive. The Reporting Person undertakes to provide to the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.46 to $13.4684, inclusive. The Reporting Person undertakes to provide to the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
BRAINSTORM CELL THERAPEUTICS INC.
CIK 0001137883
Entity typeother
Related Parties
1- filerCIK 0001521843
Filing Metadata
- Form type
- 4
- Filed
- Jul 15, 8:00 PM ET
- Accepted
- Jul 16, 5:05 PM ET
- Size
- 13.1 KB